Text Messaging Program for HIV Prevention
(SHAG Trial)
Trial Summary
What is the purpose of this trial?
SHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority boys and men 13-20 years of age across the United States. Investigators will test it against a control group that receives messages about healthy lifestyle.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators.
What data supports the effectiveness of the treatment Text Messaging Program for HIV Prevention?
Is the Text Messaging Program for HIV Prevention safe for humans?
How is the SHAG treatment for HIV prevention different from other treatments?
The SHAG treatment is unique because it uses a text messaging program to deliver HIV prevention messages and resources specifically tailored for gay, bisexual, and other men who have sex with men. This approach leverages mobile technology to provide targeted information and support, which is different from traditional in-person or medication-based HIV prevention methods.411121314
Eligibility Criteria
This trial is for cisgender sexual minority boys and men aged 13-20 in the U.S. who are interested in participating in an HIV prevention program. The eligibility criteria details are not fully provided, so additional requirements may apply.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive daily text messages for 9 weeks about healthy sexuality and ways to reduce HIV risk
Quiet Period
A 3-month period with no intervention messages
Review
Participants receive a week of review messages after the quiet period
Follow-up
Participants are monitored for HIV incidence and other outcomes post-intervention
Treatment Details
Interventions
- Healthy lifestyle control
- Sexual Health Advocacy for Guys
Sexual Health Advocacy for Guys is already approved in United States for the following indications:
- HIV prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Center for Innovative Public Health Research
Lead Sponsor